IGCS and Eisai welcomes gynecologic oncologists, oncologists, advanced practitioners (NP/PA/PharmD), and other clinicians who treat patients with gynecologic malignancies to view the first presentation from the An Evolving Frontier - Understanding Novel Treatment Options for The Management of Advanced Stage or Recurrent Endometrial Cancers Industry Supported Symposium presented at the IGCS 2023 Annual Global Meeting in Seoul, South Korea.
Second Presentation - newly available as of June 2024!
Immunotherapy After Immunotherapy, What Are The Opportunities for Immune Check-Point Inhibition Re-challenge and The Role of Pembrolizumab/Lenvatinib
Presented By:
 |
Stephanie Lheureux, MD, PhD
Princess Margaret Cancer Centre
Canada
|
STEPHANIE LHEUREUX MD, PhD is a Medical Oncologist, Clinician Investigator, Site Lead of Gynecology Oncology and co-director of the Beyond Chemotherapy Program at Princess Margaret Cancer Centre. She holds the Westaway Chair in Ovarian Cancer Research and is an Associate Professor of Faculty of Medicine at the University of Toronto. Her clinical and academic interests are focused in gynecologic cancers and early drug development with an emphasis on translational research and have garnered two ASCO Merit awards. She received the 2019 Career Development Award from the American Society of Clinical Oncology (ASCO) and the 2021 Young Investigator Award from University of Toronto Division of Medical Oncology. Internationally, she is co-Chair of the Translational Research Committee and Director representing Princess Margaret Consortium at the international Gynecologic Cancer InterGroup (GCIG). She is also a member of the Gynecologic Cancer Steering Committees at the US National Cancer Institute. In the last five years, she has >60 peer-reviewed publications in widely cited journals such as CA: Cancer Journal for Clinicians, Clinical Cancer Research, JAMA Oncology, Journal of Clinical Oncology, Lancet, Lancet Oncology and Gynecology Oncology. She is principal investigator or co-principal investigator of different clinical trials and in several large-scale peer reviewed funding opportunities from the Canadian Cancer Society Research Institute, Conquer Cancer Foundation/American Society for Clinical Oncology, Ontario Institute for Cancer Research, Ovarian Cancer Canada and Terry Fox Research Institute that converge preclinical and clinical areas of interest.
First Presentation - Released February 2024
The Evolving Treatment Landscape for The Management of Endometrial Cancer
Presented By:
 |
Ramez N. Eskander, MD
UC San Diego School of Medicine
USA
|
Ramez N. Eskander, MD, is a gynecologic oncologist who specializes in the comprehensive management of female reproductive system cancers, including ovarian, uterine, cervical, vulvar and vaginal cancer. His expertise includes therapeutic procedures, chemotherapy and novel drugs. Dr. Eskander is also experienced in clinical trial development and aims to provide individuals with access to innovative medicines during their treatment. As a clinical professor in the Department of Obstetrics, Gynecology, and Reproductive Sciences, Dr. Eskander instructs medical students, residents and fellows at University of California San Diego, School of Medicine. His research focuses on immunotherapy, targeted therapies, epigenetics and molecular diagnostics.
Attended previous IGCS webinars? If you have attended IGCS webinars in the past, you may already have an IGCS account and creating a new account is not required. If unsure of your login information, you may reset your information by selecting "Forgot Password" at login or contact education@igcs.org.
If you have questions or need assistance, contact education@igcs.org.